Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study

BACKGROUND/AIMS: Sofosbuvir plus ribavirin is a standard treatment for patients infected with chronic hepatitis C virus (HCV) genotype 2 in Korea. The purpose of this study was to examine the efficacy and safety of this treatment in Korean patients with chronic HCV genotype 2 infection. METHODS: We...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Mol Hepatol
Autori principali: Kim, Young Min, Kim, Suk Bae, Song, Il Han, Lee, Sae Hwan, Kim, Hong Soo, Lee, Tae Hee, Kang, Young Woo, Kim, Seok Hyun, Lee, Byung Seok, Chae, Hee Bok, Song, Myeong Jun, Jang, Ji Woong, Ko, Soon Young, Lee, Jae Dong
Natura: Artigo
Lingua:Inglês
Pubblicazione: The Korean Association for the Study of the Liver 2018
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6166109/
https://ncbi.nlm.nih.gov/pubmed/29865774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2017.0070
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi